While three meta-analyses have been published on the diagnostic accuracy of HE4 in lung cancer,5,6,95 only one of them reports the accuracy of HE4 specifically in patients with NSCLC , with a subgroup analysis including only 7 papers.5 This evidence concerns the gene WFDC2 and non-small cell lung carcinoma.